AAV Capsid Structure and Cell Interactions

Methods in Molecular Biology

Volumn 807, Issue , 2011, Pages 47-92

  Agbandje McKenna, Mavis ^a   Kleinschmidt, Jürgen ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

AAV capsid structure; Antibody response; Capsid assembly; Endosomal trafficking; Genome replication; Glycan receptor recognition; Internalization; Uncoating

Indexed keywords

VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ANTIBODY PRODUCTION; CHEMICAL STRUCTURE; CHEMISTRY; ENDOSOME; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; PROTEIN SECONDARY STRUCTURE; REVIEW; VIRUS CAPSID;

ANTIBODY FORMATION; CAPSID; DEPENDOVIRUS; ENDOSOMES; HUMANS; MODELS, MOLECULAR; PROTEIN STRUCTURE, SECONDARY; VIRAL PROTEINS;

EID: 83455225659     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-370-7_3     Document Type: Chapter

References (194)

1. Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., and Wilson, J. M. (2004) Clades of Adeno-associated viruses are widely disseminated in human tissues, J Virol 78, 6381–6388.
2. Gao, G. P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., and Wilson, J. M. (2002) Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy, Proc Natl Acad Sci USA 99, 11854–11859.
3. Mori, S., Wang, L., Takeuchi, T., and Kanda, T. (2004) Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein, Virology 330, 375–383.
4. Schmidt, M., Govindasamy, L., Afione, S., Kaludov, N., Agbandje-McKenna, M., and Chiorini, J. A. (2008) Molecular characterization of the heparin-dependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942), J Virol 82, 8911–8916.
5. Schmidt, M., Voutetakis, A., Afione, S., Zheng, C., Mandikian, D., and Chiorini, J. A. (2008) Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid-and heparan sulfate proteoglycan-independent transduction activity, J Virol 82, 1399–1406.
6. Chapman, M. S., and Agbandje-McKenna, M. (2006) Atomic structure if viral particles., in Parvoviruses (Kerr, J. R., Cotmore, S. F., Bloom, M. E., Linden, R. M., and Parrish, C. R., Eds.), pp 107–123, Edward Aenold Ltd. New York, New York.
7. McLaughlin, S. K., Collis, P., Hermonat, P. L., and Muzyczka, N. (1988) Adeno-associated virus general transduction vectors: analysis of proviral structures, J Virol 62, 1963–1973.
8. Samulski, R. J., Srivastava, A., Berns, K. I., and Muzyczka, N. (1983) Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV, Cell 33, 135–143.
9. Senapathy, P., Tratschin, J. D., and Carter, B. J. (1984) Replication of adeno-associated virus DNA. Complementation of naturally occurring rep-mutants by a wild-type genome or an ori-mutant and correction of terminal palindrome deletions, J Mol Biol 179, 1–20.
10. Samulski, R. J., Chang, L.-S., and Shenk, T. (1987) A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication, J Virol 61, 3096–3101.
11. Hermonat, P. L., and Muzyczka, N. (1984) Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells, Proc Natl Acad Sci USA 81, 6466–6470.
12. Samulski, R. J., Sally, M., and Muzyczka, N. (1988) Adeno-associated viral vectors., in Cold Spring Harbor, Cold Spring Harbor Laboraory Press, NY., Cold Spring Harbor.
13. Hauck, B., Chen, L., and Xiao, W. (2003) Generation and characterization of chimeric recombinant AAV vectors, Mol Ther 7, 419–425.
14. Hauck, B., and Xiao, W. (2003) Characterization of tissue tropism determinants of adeno-associated virus type 1, J Virol 77, 2768–2774.
15. Hildinger, M., Auricchio, A., Gao, G., Wang, L., Chirmule, N., and Wilson, J. M. (2001) Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer, J Virol 75, 6199–6203.
16. Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., and Samulski, R. J. (2002) Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity, J Virol 76, 791–801.
17. Rabinowitz, J. E., Bowles, D. E., Faust, S. M., Ledford, J. G., Cunningham, S. E., and Samulski, R. J. (2004) Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups, J Virol 78, 4421–4432.
18. DiMattia, M., Govindasamy, L., Levy, H. C., Gurda-Whitaker, B., Kalina, A., Kohlbrenner, E., Chiorini, J. A., McKenna, R., Muzyczka, N., Zolotukhin, S., and Agbandje-McKenna, M. (2005) Production, purification, crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 5, Acta Crystallogr Sect F Struct Biol Cryst Commun 61, 917–921.
19. Kaludov, N., Padron, E., Govindasamy, L., McKenna, R., Chiorini, J. A., and Agbandje-McKenna, M. (2003) Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 4, Virology 306, 1–6.
20. Mitchell, M., Nam, H. J., Carter, A., McCall, A., Rence, C., Bennett, A., Gurda, B., McKenna, R., Porter, M., Sakai, Y., Byrne, B. J., Muzyczka, N., Aslanidi, G., Zolotukhin, S., and Agbandje-McKenna, M. (2009) Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 9, Acta Crystallogr Sect F Struct Biol Cryst Commun 65, 715–718.
21. Miller, E. B., Gurda-Whitaker, B., Govindasamy, L., McKenna, R., Zolotukhin, S., Muzyczka, N., and Agbandje-McKenna, M. (2006) Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 1, Acta Crystallogr Sect F Struct Biol Cryst Commun 62, 1271–1274.
22. Quesada, O., Gurda, B., Govindasamy, L., McKenna, R., Kohlbrenner, E., Aslanidi, G., Zolotukhin, S., Muzyczka, N., and Agbandje-McKenna, M. (2007) Production, purification and preliminary X-ray crystallographic studies of adeno-associated virus serotype 7, Acta Crystallogr Sect F Struct Biol Cryst Commun 63, 1073–1076.
23. Lane, M. D., Nam, H. J., Padron, E., Gurda-Whitaker, B., Kohlbrenner, E., Aslanidi, G., Byrne, B., McKenna, R., Muzyczka, N., Zolotukhin, S., and Agbandje-McKenna, M. (2005) Production, purification, crystallization and preliminary X-ray analysis of adeno-associated virus serotype 8, Acta Crystallogr Sect F Struct Biol Cryst Commun 61, 558–561.
24. Govindasamy, L., Padron, E., McKenna, R., Muzyczka, N., Kaludov, N., Chiorini, J. A., and Agbandje-McKenna, M. (2006) Structurally mapping the diverse phenotype of adeno-associated virus serotype 4, J Virol 80, 11556–11570.
25. Nam, H. J., Lane, M. D., Padron, E., Gurda, B., McKenna, R., Kohlbrenner, E., Aslanidi, G., Byrne, B., Muzyczka, N., Zolotukhin, S., and Agbandje-McKenna, M. (2007) Structure of adeno-associated virus serotype 8, a gene therapy vector, J Virol 81, 12260–12271.
26. Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., and Chapman, M. S. (2002) The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy, Proc Natl Acad Sci U S A 99, 10405–10410.
27. O’Donnell, J., Taylor, K. A., and Chapman, M. S. (2009) Adeno-associated virus-2 and its primary cellular receptor – Cryo-EM structure of a heparin complex, Virology 385, 434–443.
28. Lerch, T. F., Xie, Q., Ongley, H. M., Hare, J., and Chapman, M. S. (2009) Twinned crystals of adeno-associated virus serotype 3b prove suitable for structural studies, Acta Crystallogr Sect F Struct Biol Cryst Commun 65, 177–183.
29. Xie, Q., Ongley, H. M., Hare, J., and Chapman, M. S. (2008) Crystallization and preliminary X-ray structural studies of adeno-associated virus serotype 6, Acta Crystallogr Sect F Struct Biol Cryst Commun 64, 1074–1078.
30. Padron, E., Bowman, V., Kaludov, N., Govindasamy, L., Levy, H., Nick, P., McKenna, R., Muzyczka, N., Chiorini, J. A., Baker, T. S., and Agbandje-McKenna, M. (2005) Structure of adeno-associated virus type 4, J Virol 79, 5047–5058.
31. Walters, R. W., Agbandje-McKenna, M., Bowman, V. D., Moninger, T. O., Olson, N. H., Seiler, M., Chiorini, J. A., Baker, T. S., and Zabner, J. (2004) Structure of adeno-associated virus serotype 5, J Virol 78, 3361–3371.
32. Levy, H. C., Bowman, V. D., Govindasamy, L., McKenna, R., Nash, K., Warrington, K., Chen, W., Muzyczka, N., Yan, X., Baker, T. S., and Agbandje-McKenna, M. (2009) Heparin binding induces conformational changes in Adeno-associated virus serotype 2, J Struct Biol 165, 146–156.
33. Kronenberg, S., Bottcher, B., von der Lieth, C. W., Bleker, S., and Kleinschmidt, J. A. (2005) A conformational change in the adeno-associated virus type 2 capsid leads to the exposure of hidden VP1 N termini, J Virol 79, 5296–5303.
34. Kronenberg, S., Kleinschmidt, J. A., and Bottcher, B. (2001) Electron cryo-microscopy and image reconstruction of adeno-associated virus type 2 empty capsids, EMBO Rep 2, 997–1002.
35. Lerch, T. F., Xie, Q., and Chapman, M. S. (2010) The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion, Virology, 403, 26–36.
36. Robert, N. G., Govindasamy, L., Gurda, B. L., McKenna, R., Kozyreva, O. G., Samulski, R. J., Parent, K. N., Baker, T. S., and Agbandje-McKenna, M. (2010) Structural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6, J Virol. 84, 12945–12957.
37. Bleker, S., Sonntag, F., and Kleinschmidt, J. A. (2005) Mutational analysis of narrow pores at the fivefold symmetry axes of adeno-associated virus type 2 capsids reveals a dual role in genome packaging and activation of phospholipase A2 activity, J Virol 79, 2528–2540.
38. Gerlach, B., Kleinschmidt, J. A., Böttcher, B. (2011) Conformational changes in adeno-associated virus type 1 induced by genome packaging, JMB, 409(3), 427–438 and unpublished results.
39. Kaufmann, B., Simpson, A. A., and Rossmann, M. G. (2004) The structure of human parvovirus B19, Proc Natl Acad Sci USA 101, 11628–11633.
40. Farr, G. A., Cotmore, S. F., and Tattersall, P. (2006) VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice, J Virol 80, 161–171.
41. Farr, G. A., and Tattersall, P. (2004) A conserved leucine that constricts the pore through the capsid fivefold cylinder plays a central role in parvoviral infection, Virology 323, 243–256.
42. Farr, G. A., Zhang, L. G., and Tattersall, P. (2005) Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry, Proc Natl Acad Sci U S A 102, 17148–17153.
43. Sonntag, F., Bleker, S., Leuchs, B., Fischer, R., and Kleinschmidt, J. A. (2006) Adeno-associated virus type 2 capsids with external-ized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus, J Virol 80, 11040–11054.
44. Mani, B., Baltzer, C., Valle, N., Almendral, J. M., Kempf, C., and Ros, C. (2006) Low pH-dependent endosomal processing of the incoming parvovirus minute virus of mice virion leads to externalization of the VP1 N-terminal sequence (N-VP1), N-VP2 cleavage, and uncoating of the full-length genome, J Virol 80, 1015–1024.
45. Girod, A., Wobus, C. E., Zadori, Z., Ried, M., Leike, K., Tijssen, P., Kleinschmidt, J. A., and Hallek, M. (2002) The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity, J Gen Virol 83, 973–978.
46. Zadori, Z., Szelei, J., Lacoste, M. C., Li, Y., Gariepy, S., Raymond, P., Allaire, M., Nabi, I. R., and Tijssen, P. (2001) A viral phospholipase A2 is required for parvovirus infectivity, Dev Cell 1, 291–302.
47. Kontou, M., Govindasamy, L., Nam, H. J., Bryant, N., Llamas-Saiz, A. L., Foces-Foces, C., Hernando, E., Rubio, M. P., McKenna, R., Almendral, J. M., and Agbandje-McKenna, M. (2005) Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of mice, J Virol 79, 10931–10943.
48. Bennett, A., McKenna, R., and Agbandje-McKenna, M. (2008) A comparative analysis of the structural architecture of ssDNA viruses, Computational and Mathematical Methods in Medicine Vol. 9, 183–196.
49. Summerford, C., and Samulski, R. J. (1998) Membrane-associated heparan sulfate proteo- glycan is a receptor for adeno-associated virus type 2 virions, J Virol 72, 1438–1445.
50. Chen, S., Kapturczak, M., Loiler, S. A., Zolotukhin, S., Glushakova, O. Y., Madsen, K. M., Samulski, R. J., Hauswirth, W. W., Campbell-Thompson, M., Berns, K. I., Flotte, T. R., Atkinson, M. A., Tisher, C. C., and Agarwal, A. (2005) Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors, Hum Gene Ther 16, 235–247.
51. Wu, Z., Miller, E., Agbandje-McKenna, M., and Samulski, R. J. (2006) Alpha2,3 and alpha2,6 N-linked sialic acids facilitate ef ficient binding and transduction by adeno-associated virus types 1 and 6, J Virol 80, 9093–9103.
52. Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., and Chiorini, J. A. (2001) Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglu-tination and efficient transduction but differ in sialic acid linkage specificity, J Virol 75, 6884–6893.
53. Walters, R. W., Yi, S. M., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., and Zabner, J. (2001) Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer, J Biol Chem 276, 20610–20616.
54. Di Pasquale, G., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., and Chiorini, J. A. (2003) Identification of PDGFR as a receptor for AAV-5 transduction, Nat Med 9, 1306–1312.
55. Wu, Z., Asokan, A., Grieger, J. C., Govindasamy, L., Agbandje-McKenna, M., and Samulski, R. J. (2006) Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes, J Virol 80, 11393–11397.
56. Shen, S., Brown, S. M., Randell, S. H., Asokan, A. Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9. J Biological Chemistry, 286, 13532–13540.
57. Bell, C. L., Vandenberghe, L. H., Bell, P., Limberis, M. P., Gao, G.-P., Vliet, K. V., Agbandje-McKenna, M., and Wilson, J. M. (2011) The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice, J Clin Invest, 121 (6), 2427–2435.
58. Agbandje-McKenna, M., and Chapman, M. S. (2006) Correlating structure with function in the viral capsid, in Parvoviruses (Kerr, J. R., Cotmore, S. F., Bloom, M. E., Linden, R. M., and Parrish, C. R., Eds.), Edward Arnold, New York, New York.
59. Lopez-Bueno, A., Rubio, M. P., Bryant, N., McKenna, R., Agbandje-McKenna, M., and Almendral, J. M. (2006) Host-selected amino acid changes at the sialic acid binding pocket of the parvovirus capsid modulate cell binding affinity and determine virulence, J Virol 80, 1563–1573.
60. Govindasamy, L., Hueffer, K., Parrish, C. R., and Agbandje-McKenna, M. (2003) Structures of host range-controlling regions of the capsids of canine and feline parvoviruses and mutants, J Virol 77, 12211–12221.
61. Hueffer, K., Govindasamy, L., Agbandje-McKenna, M., and Parrish, C. R. (2003) Combinations of two capsid regions controlling canine host range determine canine transferrin receptor binding by canine and feline parvoviruses, J Virol 77, 10099–10105.
62. Hafenstein, S., Palermo, L. M., Kostyuchenko, V. A., Xiao, C., Morais, M. C., Nelson, C. D., Bowman, V. D., Battisti, A. J., Chipman, P. R., Parrish, C. R., and Rossmann, M. G. (2007) Asymmetric binding of transferrin receptor to parvovirus capsids, Proc Natl Acad Sci U S A 104, 6585–6589.
63. Chipman, P. R., Agbandje-McKenna, M., Kajigaya, S., Brown, K. E., Young, N. S., Baker, T. S., and Rossmann, M. G. (1996) Cryo-electron microscopy studies of empty capsids of human parvovirus B19 complexed with its cellular receptor, Proc Natl Acad Sci U S A 93, 7502–7506.
64. Kern, A., Schmidt, K., Leder, C., Muller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., and Kleinschmidt, J. A. (2003) Identification of a heparin-binding motif on adeno-associated virus type 2 capsids, J Virol 77, 11072–11081.
65. Lochrie, M. A., Tatsuno, G. P., Christie, B., McDonnell, J. W., Zhou, S., Surosky, R., Pierce, G. F., and Colosi, P. (2006) Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization, J Virol 80, 821–834.
66. Opie, S. R., Warrington, K. H., Jr., Agbandje-McKenna, M., Zolotukhin, S., and Muzyczka, N. (2003) Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding, J Virol 77, 6995–7006.
67. Wu, P., Xiao, W., Conlon, T., Hughes, J., Agbandje-McKenna, M., Ferkol, T., Flotte, T., and Muzyczka, N. (2000) Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism, J Virol 74, 8635–8647.
68. Chen, C. L., Jensen, R. L., Schnepp, B. C., Connell, M. J., Shell, R., Sferra, T. J., Bartlett, J. S., Clark, K. R., and Johnson, P. R. (2005) Molecular characterization of adeno-associated viruses infecting children, J Virol 79, 14781–14792.
69. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., and Srivastava, A. (1999) Human fibroblast growth factor receptor 1 is a coreceptor for infection by adeno-associated virus 2, Nat Med 5, 71–77.
70. Kashiwakura, Y., Tamayose, K., Iwabuchi, K., Hirai, Y., Shimada, T., Matsumoto, K., Nakamura, T., Watanabe, M., Oshimi, K., and Daida, H. (2005) Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection, J Virol 79, 609–614.
71. Akache, B., Grimm, D., Pandey, K., Yant, S. R., Xu, H., and Kay, M. A. ( 2006) The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9, J Virol 80, 9831–9836.
72. Summerford, C., Bartlett, J. S., and Samulski, R. J. (1999) AlphaVbeta5 integrin: a coreceptor for adeno-associated virus type 2 infection, Nat Med 5, 78–82.
73. Asokan, A., Hamra, J. B., Govindasamy, L., Agbandje-McKenna, M., and Samulski, R. J. (2006) Adeno-associated virus type 2 contains an integrin alpha5beta1 binding domain essential for viral cell entry, J Virol 80, 8961–8969.
74. Duan, D., Li, Q., Kao, A. W., Yue, Y., Pessin, J. E., and Engelhardt, J. F. (1999) Dynamin is required for recombinant adeno-associated virus type 2 infection, J Virol 73, 10371–10376.
75. Bartlett, J. S., Wilcher, R., and Samulski, R. J. (2000) Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors, J Virol 74, 2777–2785.
76. Bantel-Schaal, U., Hub, B., and Kartenbeck, J. (2002) Endocytosis of adeno-associated virus type 5 leads to accumulation of virus particles in the Golgi compartment, J Virol 76, 2340–2349.
77. Bantel-Schaal, U., Braspenning-Wesch, I., and Kartenbeck, J. (2009) Adeno-associated virus type 5 exploits two different entry pathways in human embryo fibroblasts, J Gen Virol 90, 317–322.
78. Seisenberger, G., Ried, M. U., Endress, T., Buning, H., Hallek, M., and Brauchle, C. (2001) Real-time single-molecule imaging of the infection pathway of an adeno-associated virus, Science 294, 1929–1932.
79. Duan, D., Yue, Y., Yan, Z., Yang, J., and Engelhardt, J. F. (2000) Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus, J Clin Invest 105, 1573–1587.
80. Sanlioglu, S., Benson, P. K., Yang, J., Atkinson, E. M., Reynolds, T., and Engelhardt, J. F. (2000) Endocytosis and nuclear trafficking of adeno-associated virus type 2 are controlled by rac1 and phosphatidylinositol-3 kinase activation, J Virol 74, 9184–9196.
81. Qiu, J., and Brown, K. E. (1999) A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid, Virology 257, 373–382.
82. Hansen, J., Qing, K., Kwon, H. J., Mah, C., and Srivastava, A. (2000) Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts, J Virol 74, 992–996.
83. Hansen, J., Qing, K., and Srivastava, A. (2001) Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts, J Virol 75, 4080–4090.
84. Hauck, B., Zhao, W., High, K., and Xiao, W. (2004) Intracellular viral processing, not single-stranded DNA accumulation, is crucial for recombinant adeno-associated virus transduction, J Virol 78, 13678–13686.
85. Ding, W., Zhang, L. N., Yeaman, C., and Engelhardt, J. F. (2006) rAAV2 traffics through both the late and the recycling endo-somes in a dose-dependent fashion, Mol Ther 13, 671–682.
86. Ding, W., Zhang, L., Yan, Z., and Engelhardt, J. F. (2005) Intracellular trafficking of adeno-associated viral vectors, Gene Ther 12, 873–880.
87. Douar, A. M., Poulard, K., Stockholm, D., and Danos, O. (2001) Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation, J Virol 75, 1824–1833.
88. Hansen, J., Qing, K., and Srivastava, A. (2001) Adeno-associated virus type 2-mediated gene transfer: altered endocytic processing enhances transduction efficiency in murine fibroblasts, J Virol 75, 4080–4090.
89. Xiao, W., Warrington, K. H., Jr., Hearing, P., Hughes, J., and Muzyczka, N. (2002) Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2, J Virol 76, 11505–11517.
90. Pajusola, K., Gruchala, M., Joch, H., Luscher, T. F., Yla-Herttuala, S., and Bueler, H. (2002) Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells, J Virol 76, 11530–11540.
91. Akache, B., Grimm, D., Shen, X., Fuess, S., Yant, S. R., Glazer, D. S., Park, J., and Kay, M. A. (2007) A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8, Mol Ther 15, 330–339.
92. Suikkanen, S., Antila, M., Jaatinen, A., Vihinen-Ranta, M., and Vuento, M. (2003) Release of canine parvovirus from endocytic vesicles, Virology 316, 267–280.
93. Stahnke, S., Lux, K., Uhrig, S., Kreppel, F., Hösel, M., Coutelle, O., Ogris, M., Hallek, M., and Büning, H. (2011) Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles, Virology 409, 77–83. Epub 2010 Oct 25.
94. Murphy, S. L., Bhagwat, A., Edmonson, S., Zhou, S., and High, K. A. (2008) High-throughput screening and biophysical interrogation of hepatotropic AAV, Mol Ther 16, 1960–1967.
95. Agbandje-McKenna, M., Llamas-Saiz, A. L., Wang, F., Tattersall, P., and Rossmann, M. G. (1998) Functional implications of the structure of the murine parvovirus, minute virus of mice, Structure 6, 1369–1381.
96. Tsao, J., Chapman, M. S., Agbandje, M., Keller, W., Smith, K., Wu, H., Luo, M., Smith, T. J., Rossmann, M. G., Compans, R. W., and et al. (1991) The three-dimensional structure of canine parvovirus and its functional implications, Science 251, 1456–1464.
97. Xie, Q., and Chapman, M. S. (1996) Canine parvovirus capsid structure, analyzed at 2.9 A resolution, J Mol Biol 264, 497–520.
98. Grieger, J. C., Johnson, J. S., Gurda-Whitaker, B., Agbandje-McKenna, M., and Samulski, R. J. (2007) Surface-exposed adeno-associated virus Vp1-NLS capsid fusion protein rescues infectivity of noninfectious wild-type Vp2/ Vp3 and Vp3-only capsids but not that of fivefold pore mutant virions, J Virol 81, 7833–7843.
99. DiPrimio, N., Asokan, A., Govindasamy, L., Agbandje-McKenna, M., and Samulski, R. J. (2008) Surface loop dynamics in adeno-associated virus capsid assembly, J Virol 82, 5178–5189.
100. Yan, Z., Zak, R., Luxton, G. W., Ritchie, T. C., Bantel-Schaal, U., and Engelhardt, J. F. (2002) Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors, J Virol 76, 2043–2053.
101. Ding, W., Yan, Z., Zak, R., Saavedra, M., Rodman, D. M., and Engelhardt, J. F. (2003) Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia, J Virol 77, 7361–7366.
102. Yan, Z., Zak, R., Zhang, Y., Ding, W., Godwin, S., Munson, K., Peluso, R., and Engelhardt, J. F. (2004) Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia, J Virol 78, 2863–2874.
103. Denby, L., Nicklin, S. A., and Baker, A. H. (2005) Adeno-associated virus (AAV)-7 and-8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation, Gene Ther 12, 1534–1538.
104. Jennings, K., Miyamae, T., Traister, R., Marinov, A., Katakura, S., Sowders, D., Trapnell, B., Wilson, J. M., Gao, G., and Hirsch, R. (2005) Proteasome inhibition enhances AAV-mediated transgene expression in human synoviocytes in vitro and in vivo, Mol Ther 11, 600–607.
105. Zhong, L., Zhao, W., Wu, J., Li, B., Zolotukhin, S., Govindasamy, L., Agbandje-McKenna, M., and Srivastava, A. (2007) A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis, Mol Ther 15, 1323–1330.
106. Zhong, L., Li, B., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R. W., Zolotukhin, I., Warrington, K. H., Jr., Weigel-Van Aken, K. A., Hobbs, J. A., Zolotukhin, S., Muzyczka, N., and Srivastava, A. (2008) Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses, Proc Natl Acad Sci U S A 105, 7827–7832.
107. Zhong, L., Li, B., Jayandharan, G., Mah, C. S., Govindasamy, L., Agbandje-McKenna, M., Herzog, R. W., Weigel-Van Aken, K. A., Hobbs, J. A., Zolotukhin, S., Muzyczka, N., and Srivastava, A. (2008) Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression, Virology 381, 194–202.
108. Kelkar, S., De, B. P., Gao, G., Wilson, J. M., Cr ystal, R. G., and Leopold, P. L. (2006) A common mechanism for cytoplasmic dynein-dependent microtubule binding shared among adeno-associated virus and adenovirus serotypes, J Virol 80, 7781–7785.
109. Zhao, W., Zhong, L., Wu, J., Chen, L., Qing, K., Weigel-Kelley, K. A., Larsen, S. H., Shou, W., Warrington, K. H., Jr., and Srivastava, A. (2006) Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors, Virology 353, 283–293.
110. Hirosue, S., Senn, K., Clement, N., Nonnenmacher, M., Gigout, L., Linden, R. M., and Weber, T. (2007) Effect of inhibition of dynein function and microtubule-altering drugs on AAV2 transduction, Virology 367, 10–18.
111. Xu, J., Ma, C., Bass, C., and Terwilliger, E. F. (2005) A combination of mutations enhances the neurotropism of AAV-2, Virology 341, 203–214.
112. Xiao, W., Warrington, K. H., Jr., Hearing, P., Hughes, J., and Muzyczka, N. (2002) Adenovirus-facilitated nuclear translocation of adeno-associated virus type 2, J Virol 76, 11505–11517.
113. Grieger, J. C., Snowdy, S., and Samulski, R. J. (2006) Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly, J Virol 80, 5199–5210.
114. Hansen, J., Qing, K., and Srivastava, A. (2001) Infection of purified nuclei by adeno-associated virus 2, Mol Ther 4, 289–296.
115. Cohen, S., and Pante, N. (2005) Pushing the envelope: microinjection of Minute virus of mice into Xenopus oocytes causes damage to the nuclear envelope, J Gen Virol 86, 3243–3252.
116. Cohen, S., Behzad, A. R., Carroll, J. B., and Pante, N. (2006) Parvoviral nuclear import: bypassing the host nuclear-transport machinery, J Gen Virol 87, 3209–3213.
117. Sipo, I., Fechner, H., Pinkert, S., Suckau, L., Wang, X., Weger, S., and Poller, W. (2007) Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction, Gene Ther 14, 1319–1329.
118. Thomas, C. E., Storm, T. A., Huang, Z., and Kay, M. A. (2004) Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors, J Virol 78, 3110–3122.
119. Zhong, L., Li, W., Yang, Z., Qing, K., Tan, M., Hansen, J., Li, Y., Chen, L., Chan, R. J., Bischof, D., Maina, N., Weigel-Kelley, K. A., Zhao, W., Larsen, S. H., Yoder, M. C., Shou, W., and Srivastava, A. (2004) Impaired nuclear transport and uncoating limit recombinant adeno-associated virus 2 vector-mediated transduction of primary murine hematopoietic cells, Hum Gene Ther 15, 1207–1218.
120. Stieger, K., Schroeder, J., Provost, N., Mendes-Madeira, A., Belbellaa, B., Le Meur, G., Weber, M., Deschamps, J. Y., Lorenz, B., Moullier, P., and Rolling, F. (2009) Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates, Mol Ther 17, 516–523.
121. Lux, K., Goerlitz, N., Schlemminger, S., Perabo, L., Goldnau, D., Endell, J., Leike, K., Kofler, D. M., Finke, S., Hallek, M., and Buning, H. (2005) Green fluorescent pro-tein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking, J Virol 79, 11776–11787.
122. Cotmore, S. F., D’Abramo A, M., Jr., Ticknor, C. M., and Tattersall, P. (1999) Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly, Virology 254, 169–181.
123. Ros, C., Baltzer, C., Mani, B., and Kempf, C. (2006) Parvovirus uncoating in vitro reveals a mechanism of DNA release without capsid disassembly and striking differences in encapsidated DNA stability, Virology 345, 137–147.
124. Vihinen-Ranta, M., Wang, D., Weichert, W. S., and Parrish, C. R. (2002) The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection, J Virol 76, 1884–1891.
125. Ferrari, F. K., Samulski, T., Shenk, T., and Samulski, R. J. (1996) Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors, J Virol 70, 3227–3234.
126. Fisher, K. J., Gao, G., Weitzman, M. D., DeMatteo, R., Burda, J., and Wilson, J. M. (1996) Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis, J. Virol. 70, 520–532.
127. Zhong, L., Zhou, X., Li, Y., Qing, K., Xiao, X., Samulski, R. J., and Srivastava, A. (2008) Single-polarity recombinant adeno-associated virus 2 vector-mediated transgene expression in vitro and in vivo: mechanism of transduction, Mol Ther 16, 290–295.
128. Zhou, X., Zeng, X., Fan, Z., Li, C., McCown, T., Samulski, R. J., and Xiao, X. (2008) Adeno-associated virus of a single-polarity DNA genome is capable of transduction in vivo, Mol Ther 16, 494–499.
129. Qing, K., Hansen, J., Weigel-Kelley, K. A., Tan, M., Zhou, S., and Srivastava, A. (2001) Adeno-associated virus type 2-mediated gene transfer: role of cellular fkbp52 protein in transgene expression, J Virol 75, 8968–8976.
130. Qing, K., Khuntirat, B., Mah, C., Kube, D. M., Wang, X. S., Ponnazhagan, S., Zhou, S., Dwarki, V. J., Yoder, M. C., and Srivastava, A. (1998) Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo, J Virol 72, 1593–1599.
131. Qing, K., Wang, X. S., Kube, D. M., Ponnazhagan, S., Bajpai, A., and Srivastava, A. (1997) Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression, Proc Natl Acad Sci U S A 94, 10879–10884.
132. Qing, K., Li, W., Zhong, L., Tan, M., Hansen, J., Weigel-Kelley, K. A., Chen, L., Yoder, M. C., and Srivastava, A. (2003) Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo, J Virol 77, 2741–2746.
133. Nakai, H., Storm, T. A., Fuess, S., and Kay, M. A. (2003) Pathways of removal of free DNA vector ends in normal and DNA-PKcs-deficient SCID mouse hepatocytes transduced with rAAV vectors, Hum Gene Ther 14, 871–881.
134. Yue, Y., and Duan, D. (2003) Double strand interaction is the predominant pathway for intermolecular recombination of adeno-associated viral genomes, Virology 313, 1–7.
135. McCarty, D. M., Young, S. M., Jr., and Samulski, R. J. (2004) Integration of adeno-associated virus (AAV) and recombinant AAV vectors, Annu Rev Genet 38, 819–845.
136. Cervelli, T., Palacios, J. A., Zentilin, L., Mano, M., Schwartz, R. A., Weitzman, M. D., and Giacca, M. (2008) Processing of recombinant AAV genomes occurs in specific nuclear structures that overlap with foci of DNA-damage-response proteins, J Cell Sci 121, 349–357.
137. Schwartz, R. A., Palacios, J. A., Cassell, G. D., Adam, S., Giacca, M., and Weitzman, M. D. (2007) The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication, J Virol 81, 12936–12945.
138. Jurvansuu, J., Raj, K., Stasiak, A., and Beard, P. (2005) Viral transport of DNA damage that mimics a stalled replication fork, J Virol 79, 569–580.
139. Johnson, J. S., and Samulski, R. J. (2009) Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus, J Virol 83, 2632–2644.
140. Knipe, D. M., and Howley, P. M. H. (2001) Fields Viroloy, Lippincott Williams&Wilkins, Philadelphia, USA.
141. Chiorini, J. A., Wiener, S. M., Owens, R. A., Kyostio, S. R., Kotin, R. M., and Safer, B. (1994) Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats, J Virol 68, 7448–7457.
142. McCarty, D. M., Pereira, D. J., Zolotukhin, I., Zhou, X., Ryan, J. H., and Muzyczka, N. (1994) Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein, J Virol 68, 4988–4997.
143. Owens, R. A., Weitzman, M. D., Kyostio, S. R., and Carter, B. J. (1993) Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins, J Virol 67, 997–1005.
144. Snyder, R. O., Im, D. S., Ni, T., Xiao, X., Samulski, R. J., and Muzyczka, N. (1993) Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein, J Virol 67, 6096–6104.
145. Ryan, J. H., Zolotukhin, S., and Muzyczka, N. (1996) Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats, J Virol 70, 1542–1553.
146. Snyder, R. O., Samulski, R. J., and Muzyczka, N. (1990) In vitro resolution of covalently joined AAV chromosome ends, Cell 60, 105–113.
147. Im, D. S., and Muzyczka, N. (1990) The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity, Cell 61, 447–457.
148. Zhou, X., Zolotukhin, I., Im, D. S., and Muzyczka, N. (1999) Biochemical characterization of adeno-associated virus rep68 DNA helicase and ATPase activities, J Virol 73, 1580–1590.
149. Nash, K., Chen, W., and Muzyczka, N. (2008) Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteins, J Virol 82, 1458–1464.
150. Ni, T. H., McDonald, W. F., Zolotukhin, I., Melendy, T., Waga, S., Stillman, B., and Muzyczka, N. (1998) Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection, J Virol 72, 2777–2787.
151. Ward, P., Dean, F. B., O’Donnell, M. E., and Berns, K. I. (1998) Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication, J Virol 72, 420–427.
152. Stracker, T. H., Cassell, G. D., Ward, P., Loo, Y. M., van Breukelen, B., Carrington-Lawrence, S. D., Hamatake, R. K., van der Vliet, P. C., Weller, S. K., Melendy, T., and Weitzman, M. D. (2004) The Rep protein of adeno-associated virus type 2 interacts with single-stranded DNA-binding proteins that enhance viral replication, J Virol 78, 441–453.
153. Myers, M. W., and Carter, B. J. (1981) Adeno-associated virus replication. The effect of L-canavanine or a helper virus mutation on accumulation of viral capsids and progeny single-stranded DNA, J Biol Chem 256, 567–570.
154. Wistuba, A., Kern, A., Weger, S., Grimm, D., and Kleinschmidt, J. A. (1997) Subcellular compartmentalization of adeno-associated virus type 2 assembly, J Virol 71, 1341–1352.
155. Weitzman, M. D., Fisher, K. J., and Wilson, J. M. (1996) Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers, J Virol 70, 1845–1854.
156. Hunter, L. A., and Samulski, R. J. (1992) Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells, J Virol 66, 317–324.
157. Bleker, S., Pawlita, M., and Kleinschmidt, J. A. (2006) Impact of capsid conformation and Rep-capsid interactions on adeno-associated virus type 2 genome packaging, J Virol 80, 810–820.
158. Zhou, X., and Muzyczka, N. (1998) In vitro packaging of adeno-associated virus DNA, J Virol 72, 3241–3247.
159. Myers, M. W., and Carter, B. J. (1980) Assembly of adeno-associated virus, Virology 102, 71–82.
160. Bevington, J. M., Needham, P. G., Verrill, K. C., Collaco, R. F., Basrur, V., and Trempe, J. P. (2007) Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions, Virology 357, 102–113.
161. Ruffing, M., Zentgraf, H., and Kleinschmidt, J. A. (1992) Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells, J Virol 66, 6922–6930.
162. Wistuba, A., Weger, S., Kern, A., and Kleinschmidt, J. A. (1995) Intermediates of adeno-associated virus type 2 assembly: iden-tification of soluble complexes containing Rep and Cap proteins, J Virol 69, 5311–5319.
163. Steinbach, S., Wistuba, A., Bock, T., and Kleinschmidt, J. A. (1997) Assembly of adeno-associated virus type 2 capsids in vitro, J Gen Virol 78 (Pt 6), 1453–1462.
164. Hoque, M., Ishizu, K., Matsumoto, A., Han, S. I., Arisaka, F., Takayama, M., Suzuki, K., Kato, K., Kanda, T., Watanabe, H., and Handa, H. (1999) Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation, J Virol 73, 7912–7915.
165. Warrington, K. H., Jr., Gorbatyuk, O. S., Harrison, J. K., Opie, S. R., Zolotukhin, S., and Muzyczka, N. (2004) Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus, J Virol 78, 6595–6609.
166. Rabinowitz, J. E., Xiao, W., and Samulski, R. J. (1999) Insertional mutagenesis of AAV2 capsid and the production of recombinant virus, Virology 265, 274–285.
167. Sonntag et al (2010) PNAS 107, 10220–10225.
168. Prasad, K. M., and Trempe, J. P. (1995) The adeno-associated virus Rep78 protein is covalently linked to viral DNA in a preformed virion, Virology 214, 360–370.
169. Wang, X. S., Ponnazhagan, S., and Srivastava, A. (1996) Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions, J Virol 70, 1668–1677.
170. Wang, X. S., Qing, K., Ponnazhagan, S., and Srivastava, A. (1997) Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats, J Virol 71, 3077–3082.
171. Srivastava, A., Wang, X.-S., Ponnazhagan, S., Zhou, S. Z., and Yoder, M. C. (1996) Adeno-associated Virus 2-Mediated Transduction and Erythroid Lineage-Specific Expression in Human Hematopoietic Progenitor Cells, in Adeno-Associated Virus (AAV) Vectors in Gene Therapy (Berns, K. I., and Giraud, C., Eds.), pp 93–117, Springer, Berlin Heidelberg New York.
172. Xiao, X., Xiao, W., Li, J., and Samulski, R. J. (1997) A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle, J Virol 71, 941–948.
173. Dong, J. Y., Fan, P. D., and Frizzell, R. A. (1996) Quantitative analysis of the packaging capacity of recombinant adeno-associated virus, Hum Gene Ther 7, 2101–2112.
174. Hermonat, P. L., Quirk, J. G., Bishop, B. M., and Han, L. (1997) The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors, FEBS Lett 407, 78–84.
175. Grieger, J. C., and Samulski, R. J. (2005) Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps, J Virol 79, 9933–9944.
176. Allocca, M., Doria, M., Petrillo, M., Colella, P., Garcia-Hoyos, M., Gibbs, D., Kim, S. R., Maguire, A., Rex, T. S., Di Vicino, U., Cutillo, L., Sparrow, J. R., Williams, D. S., Bennett, J., and Auricchio, A. (2008) Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice, J Clin Invest 118, 1955–1964.
177. Lai, Y., Yue, Y., and Duan, D. Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb, Mol Ther 18, 75–79.
178. Dong, B., Nakai, H., and Xiao, W. Characterization of genome integrity for oversized recombinant AAV vector, Mol Ther 18, 87–92.
179. Wu, Z., Yang, H., and Colosi, P. Effect of genome size on AAV vector packaging, Mol Ther 18, 80–86.
180. Ward, P., Clement, N., and Linden, R. M. (2007) cis effects in adeno-associated virus type 2 replication, J Virol 81, 9976–9989.
181. Grimm, D., Kern, A., Pawlita, M., Ferrari, F., Samulski, R., and Kleinschmidt, J. (1999) Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2, Gene Ther 6, 1322–1330.
182. Drittanti, L., Jenny, C., Poulard, K., Samba, A., Manceau, P., Soria, N., Vincent, N., Danos, O., and Vega, M. (2001) Optimised helper virus-free production of high-quality adeno-associated virus vectors, J Gene Med 3, 59–71.
183. Sommer, J. M., Smith, P. H., Parthasarathy, S., Isaacs, J., Vijay, S., Kieran, J., Powell, S. K., McClelland, A., and Wright, J. F. (2003) Quantification of adeno-associated virus particles and empty capsids by optical density measurement, Mol Ther 7, 122–128.
184. Park, J. Y., Lim, B. P., Lee, K., Kim, Y. G., and Jo, E. C. (2006) Scalable production of adeno-associated virus type 2 vectors via suspension transfection, Biotechnol Bioeng 94, 416–430.
185. Prasad, K. M., Zhou, C., and Trempe, J. P. (1997) Characterization of the Rep78/ adeno-associated virus complex, Virology 229, 183–192.
186. Dubielzig, R., King, J. A., Weger, S., Kern, A., and Kleinschmidt, J. A. (1999) Adeno-associated virus type 2 protein interactions: formation of pre-encapsidation complexes, J Virol 73, 8989–8998.
187. Chejanovsky, N., and Carter, B. J. (1989) Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication, Virology 173, 120–128.
188. King, J. A., Dubielzig, R., Grimm, D., and Kleinschmidt, J. A. (2001) DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids, Embo J 20, 3282–3291.
189. Yoon-Robarts, M., Blouin, A. G., Bleker, S., Kleinschmidt, J. A., Aggarwal, A. K., Escalante, C. R., and Linden, R. M. (2004) Residues within the B’ motif are critical for DNA binding by the superfamily 3 helicase Rep40 of adeno-associated virus type 2, J Biol Chem 279, 50472–50481.
190. Shi, W., Arnold, G. S., and Bartlett, J. S. (2001) Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors, Hum Gene Ther 12, 1697–1711.
191. Zaiss and Muruve (2008) Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Gene Therapy 15, 808–16.
192. Moskalenko, M., Chen, L., van Roey, M., Donahue, B. A., Snyder, R. O., McArthur, J. G., and Patel, S. D. (2000) Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure, J Virol 74, 1761–1766.
193. Wobus, C. E., Hugle-Dorr, B., Girod, A., Petersen, G., Hallek, M., and Kleinschmidt, J. A. (2000) Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection, J Virol 74, 9281–9293.
194. Kuck, D., Kern, A., and Kleinschmidt, J. A. (2007) Development of AAV serotype-specific ELISAs using novel monoclonal antibodies, J Virol Methods 140, 17–24.